by Asa Elmore | Sep 3, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma to Present at Two Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 3, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...
by Asa Elmore | Sep 2, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting Ongoing Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not...
by Asa Elmore | Aug 25, 2020 | News, Press Releases
Sutro Biopharma Earns Clinical Supply Milestone Payment from Merck KGaA, Darmstadt, Germany for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors SOUTH SAN FRANCISCO, Calif., August 25, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug...
by Asa Elmore | Aug 11, 2020 | News, Press Releases
Sutro Biopharma Announces Two Executive Promotions to Vice President of Quality and Vice President of Manufacturing Mr. Carlos Lugo promoted to Vice President of Quality and CMC Regulatory Operations Mr. Devendra Luhar promoted to Vice President of Manufacturing &...
by Asa Elmore | Aug 10, 2020 | Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference SOUTH SAN FRANCISCO, Calif., August 10, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application...
by Asa Elmore | Aug 6, 2020 | News, Press Releases
Sutro Biopharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights and Developments Encouraging STRO-002 Interim Phase 1 Clinical Data Presented at the AACR Virtual Meeting in April STRO-002 Preclinical Data Presented at 2020 AACR Virtual...
